PCN11 ASSESSING THE TREATMENT EFFECT OF RASBURICASE ALONE VERSUS RASBURICASE AND ALLOPURINOL COMBINATION THERAPY USING PROPENSITY SCORES

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A randomized comparison between rasburicase and allopurinol in children

Leonard Johnson, Conrad Tou, Elizabeth Harvey, Erin Morris and Mitchell S. Cairo Stanton C. Goldman, John S. Holcenberg, Jerry Z. Finklestein, Raymond Hutchinson, Susan Kreissman, F. December 1998. the American Society of Hematology Conference in Miami Beach, FL, with lymphoma or leukemia at high risk for tumor lysis : Presented in part at A randomized comparison between rasburicase and allopur...

متن کامل

Effects of Recombinant Urate Oxidase (Rasburicase) and Allopurinol for Prophylaxis and Treatment of Hyperuricemia in Patients with Leukemia and Lymphoma

Background: Efficacy of rasburicase in pediatric patients with leukemia and lymphoma is proved. This study aims toweigh efficacy and safety of rasburicase versus more conventional therapy, allopurinol, and to compare their safetyand properties in tumor lysis syndrome (TLS) of leukemia and lymphoma patients.Materials and Methods: The study was done with a retrospective cohort design. Patients we...

متن کامل

Economic implications of rasburicase treatment in adult patients with tumour lysis syndrome.

BACKGROUND Rasburicase is a recombinant urate-oxidase enzyme used to reduce high levels of plasma uric acid (PUA) resulting from tumour lysis syndrome (TLS). Rasburicase reduces PUA levels within 4 hours of administration, thereby minimizing the risk of serious complications from TLS. Treatment pattern analyses indicate rasburicase is often used in combination with allopurinol; however, no stud...

متن کامل

Sample preparation in patients receiving uric acid oxidase (rasburicase) therapy.

etary riboflavin, neither were they related to EGRAC or plasma ribofla-vin. This supports the use of EGRAC, and, to a lesser extent, plasma ribo-flavin, as a marker of riboflavin status that reflects dietary intake. We do not agree with the suggestion that the improvement in folate status in the folate-rich diet should have compromised riboflavin status, as it did in the folic acid supplemen-ta...

متن کامل

Rasburicase for acute kidney injury.

BACKGROUND Acute kidney injury (AKI) continues to have significant mortality and morbidity and the search is on for any novel therapeutic intervention. CASE CHARACTERISTICS Two cases of AKI with elevated SUA (serum uric acid). INTERVENTION Rasburicase. OUTCOME In Case 1 (late preterm male with AKI) rasburicase resulted in a significant reduction of SUA along with improvement in renal para...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2010

ISSN: 1098-3015

DOI: 10.1016/s1098-3015(10)72102-1